Effects of renal function on the pharmacokinetics and pharmacodynamics of prophylactic cefazolin in cardiothoracic surgery

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 31, Issue 2, 2012, Pages 193-199

  Kosaka, T ^a   Hosokawa, K ^a   Shime, N ^a   Taniguchi, F ^a   Kokufu, T ^a   Hashimoto, S ^a   Fujiwara, H ^a   Yaku, H ^a   Sugioka, N ^b   Okada, K ^a   Fujita, N ^a  

^a KYOTO PREFECTURAL UNIVERSITY   (Japan)

^b KOBE GAKUIN UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CEFAMEZIN ALPHA; CEFAZOLIN; CREATININE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CARDIOPULMONARY BYPASS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE CLEARANCE; DISTRIBUTION VOLUME; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG ELIMINATION; DRUG HALF LIFE; FEMALE; HEART SURGERY; HEMODIALYSIS; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; PHARMACODYNAMICS; PRIORITY JOURNAL; SURGICAL INFECTION;

AGED; ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; CARDIAC SURGICAL PROCEDURES; CARDIOPULMONARY BYPASS; CEFAZOLIN; FEMALE; HUMANS; KIDNEY; KIDNEY FUNCTION TESTS; KINETICS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; THORACIC SURGICAL PROCEDURES;

EID: 84857056785     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-011-1293-z     Document Type: Article

References (27)

1. SA Zelenitsky RE Silverman H Duckworth GK Harding 2000 A prospective, randomized, double-blind study of single high dose versus multiple standard dose gentamicin both in combination with metronidazole for colorectal surgical prophylaxis J Hosp Infect 46 135 40 11049707 10.1053/jhin.2000.0814 1:STN:280:DC%2BD3M%2FjtFalsA%3D%3D
2. SA Zelenitsky RE Ariano GK Harding RE Silverman 2002 Antibiotic pharmacodynamics in surgical prophylaxis: an association between intraoperative antibiotic concentrations and efficacy Antimicrob Agents Chemother 46 9 3026 30 12183263 10.1128/AAC.46.9.3026-3030.2002 1:CAS:528:DC%2BD38Xmtl2ktbo%3D
3. S Harbarth MH Samore D Lichtenberg Y Carmeli 2000 Prolonged antibiotic prophylaxis after cardiovascular surgery and its effect on surgical site infections and antimicrobial resistance Circulation 101 2916 2921 10869263 1:CAS:528:DC%2BD3cXkvFWlsbo%3D (Pubitemid 30415881)
4. L Prokuski 2008 Prophylactic antibiotics in orthopaedic surgery J Am Acad Orthop Surg 16 283 293 18460689
5. IC Gyssens 1999 Preventing postoperative infections: current treatment recommendations Drugs 57 175 185 10188759 10.2165/00003495-199957020-00004 1:CAS:528:DyaK1MXitVWqu7g%3D (Pubitemid 29116507)
6. CH Nightingale DS Greene R Quintiliani 1975 Pharmacokinetics and clinical use of cephalosporin antibiotics J Pharm Sci 64 1899 1926 1107514 10.1002/jps.2600641202 1:CAS:528:DyaE28XmvFWhtA%3D%3D
7. WM Kirby C Regamey 1973 Pharmacokinetics of cefazolin compared with four other cephalosporins J Infect Dis 128 Suppl S341 346 4744015 10.1093/infdis/128.Supplement-2.S341 1:CAS:528:DyaE2cXhtVCisb8%3D
8. T Bergan EK Brodwall O Orjavik 1977 Pharmacokinetics of cefazolin patients with normal and impaired renal function J Antimicrob Chemother 3 435 443 903324 10.1093/jac/3.5.435 1:STN:280:DyaE1c%2FgsFCisg%3D%3D (Pubitemid 8186492)
9. WA Craig 1998 Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men Clin Infect Dis 26 1 10 9455502 10.1086/516284 1:CAS:528:DyaK1cXltVaqtw%3D%3D
10. KJ Schaper S Schubert A Dalhoff 2005 Kinetics and quantification of antibacterial effects of beta-lactams, macrolides, and quinolones against gram-positive and gram-negative RTI pathogens Infection 33 Suppl 2 3 14 16518706 10.1007/s15010-005-8202-2 1:CAS:528:DC%2BD28Xhs1KhtrY%3D
11. DP Nicolau R Quintiliani 1994 Choosing between the new cephalosporin antibiotics: a pharmacodynamic approach Pharmacoeconomics 5 Suppl 2 34 39 10147287 10.2165/00019053-199400052-00007 1:STN:280:DyaK2cbgvFymug%3D%3D
12. TP Bechtel RL Slaughter TD Moore 1980 Seizures associated with high cerebrospinal fluid concentrations of cefazolin Am J Hosp Pharm 37 271 273 7361804 1:STN:280:DyaL3c7ltV2itA%3D%3D (Pubitemid 10144504)
13. DW Bratzler PM Houck 2004 Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project Clin Infect Dis 38 1706 1715 15227616 10.1086/421095 (Pubitemid 38781662)
14. CE Edmiston C Krepel H Kelly J Larson D Andris C Hennen A Nakeeb JR Wallace 2004 Perioperative antibiotic prophylaxis in the gastric bypass patient: do we achieve therapeutic levels? Surgery 136 738 747 15467657 10.1016/j.surg.2004.06.022 (Pubitemid 39311298)
15. SM Swoboda C Merz J Kostuik B Trentler PA Lipsett 1996 Does intraoperative blood loss affect antibiotic serum and tissue concentrations? Arch Surg 131 1165 1171 8911256 10.1001/archsurg.1996.01430230047009 1:STN:280:DyaK2s%2Fmsl2hug%3D%3D
16. AD Caffarelli JP Holden EJ Baron HJ Lemmens H D'Souza V Yau C Olcott 4th BA Reitz DC Miller PJ van der Starre 2006 Plasma cefazolin levels during cardiovascular surgery: effects of cardiopulmonary bypass and profound hypothermic circulatory arrest J Thorac Cardiovasc Surg 131 1338 1343 16733167 10.1016/j.jtcvs.2005.11.047 1:CAS:528:DC%2BD28XmsFaqsbc%3D (Pubitemid 43776060)
17. DW Cockcroft MH Gault 1976 Prediction of creatinine clearance from serum creatinine Nephron 16 31 41 1244564 10.1159/000180580 1:STN:280: DyaE28%2FnsF2isw%3D%3D
18. A Fukumoto M Yamagishi K Doi M Ogawa T Inoue S Hashimoto H Yaku 2006 Hemodiafiltration during cardiac surgery in patients on chronic hemodialysis J Card Surg 21 553 558 17073952 10.1111/j.1540-8191.2006.00295.x (Pubitemid 44657152)
19. G Nygard SK Wahba Khalil 1984 An isocratic HPLC method for the determination of cephalosporins in plasma J Liquid Chromatogr 7 1461 1475 10.1080/01483918408074058 1:CAS:528:DyaL2cXks1Gnsb0%3D (Pubitemid 14088759)
20. TM Bergamini HC Polk Jr 1989 Pharmacodynamics of antibiotic penetration of tissue and surgical prophylaxis Surg Gynecol Obstet 168 283 289 2645669 1:STN:280:DyaL1M7ks1Grsw%3D%3D (Pubitemid 19114473)
21. R Engelman D Shahian R Shemin TS Guy D Bratzler F Edwards M Jacobs H Fernando C Bridges Workforce on Evidence-Based Medicine, Society of Thoracic Surgeons, 2007 The Society of Thoracic Surgeons practice guideline series: Antibiotic prophylaxis in cardiac surgery, part II: Antibiotic choice Ann Thorac Surg 83 1569 1576 17383396 10.1016/j.athoracsur.2006.09.046 (Pubitemid 46463914)
22. GR Brown 1993 Cephalosporin-probenecid drug interactions Clin Pharmacokinet 24 289 300 8491057 10.2165/00003088-199324040-00003 1:CAS:528:DyaK3sXksVSjt7o%3D (Pubitemid 23113260)
23. R Hori K Okumura A Kamiya H Nihira H Nakano 1983 Ampicillin and cephalexin in renal insufficiency Clin Pharmacol Ther 34 792 798 6641095 10.1038/clpt.1983.251 1:STN:280:DyaL2c%2Fls1arsg%3D%3D (Pubitemid 14219927)
24. T Madhavan K Yaremchuk N Levin E Fisher F Cox K Burch E Haas D Pohlod EL Quinn 1975 Effects of renal failure and dialysis on cefazolin pharmacokinetics Antimicrob Agents Chemother 8 63 66 1164008 1:STN:280:DyaE28%2FhslCmug%3D%3D
25. JJ Lehot 2004 Cefazolin prophylaxis during cardiac operations Ann Thorac Surg 77 755 756 14759489 10.1016/S0003-4975(03)01429-2 (Pubitemid 38186559)
26. GL Drusano 2003 Prevention of resistance: a goal for dose selection for antimicrobial agents Clin Infect Dis 36 Suppl1 S42 S50 12516029 10.1086/344653 1:CAS:528:DC%2BD3sXht1ynu7o%3D (Pubitemid 36140468)
27. PS McKinnon JA Paladino JJ Schentag 2008 Evaluation of area under the inhibitory curve (AUIC) and time above the minimum inhibitory concentration (T > MIC) as predictors of outcome for cefepime and ceftazidime in serious bacterial infections Int J Antimicrob Agents 31 345 351 18313273 10.1016/j.ijantimicag.2007.12.009 1:CAS:528:DC%2BD1cXjs1Kgtro%3D